Urologic OncologyUnited States
Weill Cornell Medicine / NewYork-Presbyterian
New York, NY
Two-year fellowship, established in 2010, with a clinical component in complex cancer surgery by open, laparoscopic and robotic approaches plus GU medical and radiation oncology rotations, and one research year.
Length2 years (clinical and research components)
SUO accredited
What stands out
- Early Detection Research Network prostate biomarker work led by the program director, backed by a tissue bank
- Clinical kidney, prostate and bladder cancer databases, a biospecimen repository and a tumor registry
- Department houses the Center for Prostate Cancer Imaging, Diagnosis and Focused Therapy
- LeFrak Center for Robotic Surgery in the department is evaluating MRI-guided prostate biopsy
- Program lead
- Douglas Scherr
- Apply through
- AUA / SUO Match
- Timeline
- At least 19 months before residency completion (by December 1 of the year before chief residency)
- Focus
- All aspects of urologic oncology with surgical emphasis including minimally invasive techniques; medical and radiation oncology rotations; research
- Eligibility
- Open to Canadian-trained applicantsUSMLE / ECFMG only for international graduatesVisa: not stated
- Contact
- Loading contact…
Training
- Structure
- Two years: a clinical component and one year of basic and/or clinical research
- Research
- Research year in basic, translational or outcomes science; didactics in biostatistics, epidemiology, tumor biology and trial design
- Case numbers
- Over 200 prostatectomies per year by Douglas Scherr (individual surgeon)
- Hospital
- NewYork-Presbyterian Hospital / Weill Cornell Medical Center
Requirements (4)
- Completed an approved general urology residency
- Eligible for a New York State medical licence
- Foreign graduates: valid ECFMG certificate and all three USMLE parts
- CV, three letters (including program director), diploma, transcript, residency certificates, letter of good standing, USMLE transcript